Back to Search
EDITH PEREZ, MD
MD
Hematology & Oncology Physician
NPI: 1861481590Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME68544(FL)
Research & Publications (20)
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
PMID 19625343·Ann Oncol·2010
3-trial
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance.
PMID 19671735·Mol Cancer Ther·2009
6-review
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.
PMID 18443902·Breast Cancer Res Treat·2009
6-review
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PMID 18325918·Ann Oncol·2008
8-other
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
PMID 18250349·J Clin Oncol·2008
3-trial
Cardiac toxicity of ErbB2-targeted therapies: what do we know?
PMID 18777950·Clin Breast Cancer·2008
6-review
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials.
PMID 18533085·Mayo Clin Proc·2008
8-other
Safety of aromatase inhibitors in the adjuvant setting.
PMID 17912638·Breast Cancer Res Treat·2007
4-observational
Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.
PMID 17890211·Ann Oncol·2007
6-review
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.
PMID 17606974·J Clin Oncol·2007
3-trial
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
PMID 16809727·J Clin Oncol·2006
4-observational
Optimizing adjuvant chemotherapy in early-stage breast cancer.
PMID 16506631·Oncology (Williston Park)·2005
6-review
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.
PMID 16381626·Clin Breast Cancer·2005
3-trial
Management recommendations for adjuvant systemic breast cancer therapy.
PMID 15687718·Breast Dis·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4500 SAN PABLO RD S
JACKSONVILLE, FL 32224 - Phone
- (904) 953-2000
Quick Facts
- NPI
- 1861481590
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile